ResMed

From Wikipedia, the free encyclopedia
Jump to: navigation, search
ResMed
Public
Traded as NYSERMD
ASXRMD
Industry Medical
Founded 1989
Headquarters San Diego, California
Key people
  • Peter C. Farrell, Founder and Chairman
  • Michael "Mick" Farrell, CEO
  • Robert Douglas, President and COO
Products Medical equipment for sleep-disordered breathing and other respiratory disorders
Website www.resmed.com

ResMed is a global manufacturer of CPAP masks, machines and other products that diagnose, treat or help manage sleep-disordered breathing (particularly sleep apnea), chronic obstructive pulmonary disease (COPD), or other respiratory conditions. For the general public, the company offers a non-contact sleep monitor, the S+ by ResMed, currently available in the US.

ResMed employs more than 4,000 employees worldwide, operates in 100 countries and has manufacturing facilities in Australia, France, Singapore and the US. It achieved revenues of $1.5 billion USD in fiscal year 2013–14.[1]

As part of its mission, ResMed seeks to spread awareness of the prevalence of sleep apnea, since more than 80% of cases are believed to be undiagnosed.[2] More than 70% of people with obesity,[3] heart failure,[4] type 2 diabetes,[5] and drug-resistant hypertension[6] have some form of sleep-disordered breathing.

History[edit]

In 1980, Professor Colin Sullivan invented the first continuous positive airway pressure (CPAP) machine, regarded today as the “gold standard” in sleep apnea treatment. ResMed launched in 1989 when founder Peter Farrell sought to expand the general public’s access to CPAP treatment. In addition to CPAP machines and masks, the company has since grown to produce CPAP humidifiers, heated tubes and other accessories, as well as diagnostic tools, hospital CPAP machines and life support ventilators. It has also expanded into healthcare informatics, with software solutions that enable patients and medical professionals to wirelessly monitor sleep data.

See also[edit]

References[edit]